BDBM50105465 (4R,8S,11S,17S)-8-(4-Amino-butyl)-17-(2-amino-3-naphthyl-propionylamino)-6-tert-butyl-11-(1H-indol-3-ylmethyl)-7,10,13,16-tetraoxo-14-pyridin-3-ylmethyl-1,2-dithia-5,9,12,15-tetraaza-cyclooctadecane-4-carboxylic acid (1-carbamoyl-2-(m-fluoro-phenyl)-ethyl)-amide::CHEMBL429000

SMILES CC(C)(C)C1N[C@@H](CSSC[C@@H](NC(=O)C(N)Cc2cccc(F)c2)C(=O)NC(Cc2cccnc2)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CCCCN)C1=O)C(=O)NC(Cc1cccc2ccccc12)C(N)=O

InChI Key InChIKey=AYTGIPIZQAAKOB-BGRKUYOQSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50105465   

TargetSomatostatin receptor type 2(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50105465((4R,8S,11S,17S)-8-(4-Amino-butyl)-17-(2-amino-3-na...)
Affinity DataIC50:  270nMAssay Description:Antagonistic activity of the compound towards sst2 receptor in GH4C1 cells a concentration of 1-2 x 10e6/mL incubated for 20 minutesMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 2(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50105465((4R,8S,11S,17S)-8-(4-Amino-butyl)-17-(2-amino-3-na...)
Affinity DataIC50:  4.10nMAssay Description:Inhibitory concentration of the compound towards binding of sst2 receptor using [125I]-somatostatin as radioligand in Neuro2A cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed